Determining When Dual-Use Nanoparticle Injections are Used as Bioweapons vs. Vaccines
How do governments and citizens accurately categorize dual-use clinical research products and technologies that were developed for end-use military purposes or agents of biowarfare?
March 17, 2024: How do governments and citizens accurately categorize dual-use research (DURC) products and technologies that were developed for end-use military purposes (such as the engineered nanoparticles used in the COVID-19 mRNA nanoparticle injections) if their clinical outcomes have no semblance to a vaccine, but clinically and legally match the…
Keep reading with a 7-day free trial
Subscribe to The Kingston Report to keep reading this post and get 7 days of free access to the full post archives.